Received Jun 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MEN | MENINGOCOCCAL (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | — | OT / LA |
15 year old was given MENQUADFI a month early with no reported AE; Initial information received on 09-Jun-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 15 years old male patient who was given Meningococcal A-C-Y-W135 (T Conj) Vaccine [Menquadfi] a month early with no reported ae (adverse event). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient who was given a dose 2 of suspect Meningococcal A-C-Y-W135 (T Conj) Vaccine Solution for injection Frequency = once (strength standard) (batch, dose, expiry date unknown) via unknown route in the left arm for Immunization a month early with no reported ae (inappropriate schedule of product administration) (same day latency). Information on batch number and expiry date corresponding to the one at time of event occurrence was requested. Action taken: not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.